Pathology, research and practice
TCN1 knockdown inhibits the progression and glycolysis of non-small cell lung cancer via regulating B3GNT3.
Hui Zhou, Yayun Cui, Lailing Li
Published: 202610.1016/j.prp.2026.156376
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality globally. Transcobalamin 1 (TCN1) is a driver associated with the progression of various cancers. However, the role of TCN1 in NSCLC remains elusive. The current rese…
Preview only. Read the full abstract at the source